Sage Journals: Discover world-class research

Retricted access

Review article

First published 2023-8

Vericiguat: The First Soluble Guanylate Cyclase Stimulator for Reduction of Cardiovascular Death and Heart Failure Hospitalization in Patients With Heart Failure Reduced Ejection Fraction

Bao-Anh Tran, Erini S. Serag-Bolos, Joel Fernandez [...]

Journal of Pharmacy Practice

Open access

Letter

First published 2018-1

Riociguat,a soluble guanylate cyclase stimulator,ameliorates right ventricular contraction in pulmonary arterial hypertension

Mitsushige Murata, Takashi Kawakami, Masaharu Kataoka [...]

Pulmonary Circulation

Retricted access

Review article

First published 2022-5

Vericiguat: A Novel Oral Soluble Guanylate Cyclase Stimulator for the Treatment of Heart Failure

Nicole Campbell, Julie Kalabalik-Hoganson, Kathleen Frey

Annals of Pharmacotherapy

Open access

Research article

First published 2021-1

Hemodynamic Effects of a Soluble Guanylate Cyclase Stimulator,Riociguat,and an Activator,Cinaciguat,During NO-Modulation in Healthy Pigs

Torvind Næsheim, Ole-Jakob How, Truls Myrmel

Journal of Cardiovascular Pharmacology and Therapeutics

Free access

Research article

First published 2016-3

Effects of Age and Sex on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Reiner Frey, Soundos Saleh, Corina Becker [...]

Pulmonary Circulation

Free access

Research article

First published 2016-3

Assessment of the Effects of Hepatic Impairment and Smoking on the Pharmacokinetics of a Single Oral Dose of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Reiner Frey, Corina Becker, Sigrun Unger [...]

Pulmonary Circulation

Free access

Research article

First published 2016-3

Assessment of the Effects of Renal Impairment and Smoking on the Pharmacokinetics of a Single Oral Dose of the Soluble Guanylate Cyclase Stimulator Riociguat (BAY 63-2521)

Reiner Frey, Corina Becker, Sigrun Unger [...]

Pulmonary Circulation

Free access

Review article

First published 2021-11

The Role of sGC Stimulators and Activators in Heart Failure With Reduced Ejection Fraction

David J. Cordwin, Theodore J. Berei, Kristen T. Pogue

Journal of Cardiovascular Pharmacology and Therapeutics

Open access

Case report

First published 2017-8

Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series

Amresh Raina, Raymond L. Benza, Harrison W. Farber

Pulmonary Circulation

Open access

Case report

First published 2018-1

First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension

Till Spreemann, Harald Bertram, Christoph M. Happel [...]

Pulmonary Circulation

Search results